WuXi Biologics - Free Cash Flow To Equity

WuXi Biologics's Fiscal Year is From January To December - All Figures are in CNY, Billions.

The item "Free-Cash-Flow-To-Equity" stands at 0.7581 Billion Chinese Yuans for the trailing twelve months (TTM) period ending 09/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.7477 Billion Chinese Yuans compared to the value the year prior.
The 1 year change is 0.7477 Billion Chinese Yuans.
The 3 year change is 4.92 Billion Chinese Yuans.
The 5 year change is 1.70 Billion Chinese Yuans.

The Serie's long term average value is -1.62 Billion Chinese Yuans. It's latest available value, on 09/30/2023, is 2.38 Billion Chinese Yuans higher, compared to it's long term average value.
The Serie's change in Chinese Yuans from it's minimum value, on 06/30/2021, to it's latest available value, on 09/30/2023, is +8.02 Billion.
The Serie's change in Chinese Yuans from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2023, is -1.90 Billion.